This post is from a suggested group
The US Plasma Fractionation Market: Securing the Supply Chain of Life-Saving Plasma-Derived Therapies, Addressing Chronic Demand for Immunoglobulins, and Navigating Regulatory Scrutiny in Blood Product Collection
The US Plasma Fractionation Market is a highly specialized and vital sector of the biopharmaceutical industry, focused on separating and purifying specific proteins from human blood plasma to create life-saving therapies, driven by a chronic and escalating clinical demand for these essential products. The primary market catalyst is the rapidly increasing use of Intravenous Immunoglobulin (IVIg) and Subcutaneous Immunoglobulin (SCIg), which are critical treatments for a wide range of primary and secondary immune deficiencies, neurological disorders (e.g., CIDP), and autoimmune diseases. The discussion must emphasize that the United States is the largest global supplier of source plasma, owing to a robust and regulated paid donor system that fuels the high-volume fractionation process. Furthermore, plasma-derived products such as Albumin are essential for managing critically ill…